Positive effects of carbamazepine on behavioral dyscontrol in borderline personality disorder.
Am J Psychiatry
; 143(4): 519-22, 1986 Apr.
Article
em En
| MEDLINE
| ID: mdl-3513634
ABSTRACT
In a double-blind crossover trial, carbamazepine, an anticonvulsant with primary effects on subcortical limbic structures, decreased the severity of behavioral dyscontrol in 11 women with borderline personality disorder significantly more than placebo. The authors emphasize the preliminary nature of their findings and discuss alternative hypotheses regarding mechanisms by which carbamazepine might influence behavioral dyscontrol.
Buscar no Google
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Transtornos da Personalidade
/
Transtorno da Personalidade Borderline
/
Carbamazepina
Tipo de estudo:
Clinical_trials
Limite:
Adult
/
Female
/
Humans
Idioma:
En
Revista:
Am J Psychiatry
Ano de publicação:
1986
Tipo de documento:
Article